360 related articles for article (PubMed ID: 29321207)
21. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
[TBL] [Abstract][Full Text] [Related]
22. PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development.
Chan CB; Liu X; Ensslin MA; Dillehay DL; Ormandy CJ; Sohn P; Serra R; Ye K
EMBO J; 2010 Mar; 29(5):956-68. PubMed ID: 20075866
[TBL] [Abstract][Full Text] [Related]
23. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.
Chughtai N; Schimchowitsch S; Lebrun JJ; Ali S
J Biol Chem; 2002 Aug; 277(34):31107-14. PubMed ID: 12060651
[TBL] [Abstract][Full Text] [Related]
24. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
Hou L; Xu B; Mohankumar KM; Goffin V; Perry JK; Lobie PE; Liu DX
Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
[TBL] [Abstract][Full Text] [Related]
25. Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells.
Schauwecker SM; Kim JJ; Licht JD; Clevenger CV
J Biol Chem; 2017 Feb; 292(6):2237-2254. PubMed ID: 28035005
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine phosphorylation of Grb2: role in prolactin/epidermal growth factor cross talk in mammary epithelial cell growth and differentiation.
Haines E; Minoo P; Feng Z; Resalatpanah N; Nie XM; Campiglio M; Alvarez L; Cocolakis E; Ridha M; Di Fulvio M; Gomez-Cambronero J; Lebrun JJ; Ali S
Mol Cell Biol; 2009 May; 29(10):2505-20. PubMed ID: 19273609
[TBL] [Abstract][Full Text] [Related]
27. Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.
Furth PA; Nakles RE; Millman S; Diaz-Cruz ES; Cabrera MC
Breast Cancer Res; 2011 Oct; 13(5):220. PubMed ID: 22018398
[TBL] [Abstract][Full Text] [Related]
28. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.
Horsch K; Schaller MD; Hynes NE
Mol Endocrinol; 2001 Dec; 15(12):2182-96. PubMed ID: 11731619
[TBL] [Abstract][Full Text] [Related]
29. Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.
Tarulli GA; De Silva D; Ho V; Kunasegaran K; Ghosh K; Tan BC; Bulavin DV; Pietersen AM
Breast Cancer Res; 2013 Jan; 15(1):R10. PubMed ID: 23369183
[TBL] [Abstract][Full Text] [Related]
30. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context.
Gutzman JH; Rugowski DE; Nikolai SE; Schuler LA
Oncogene; 2007 Sep; 26(43):6341-8. PubMed ID: 17438530
[TBL] [Abstract][Full Text] [Related]
31. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J
Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015
[TBL] [Abstract][Full Text] [Related]
32. Serotonin suppresses β-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A.
Chiba T; Kimura S; Takahashi K; Morimoto Y; Sanbe A; Ueda H; Kudo K
Biol Pharm Bull; 2014; 37(8):1336-40. PubMed ID: 25087955
[TBL] [Abstract][Full Text] [Related]
33. Global profiling of prolactin-modulated transcripts in breast cancer in vivo.
Sato T; Tran TH; Peck AR; Liu C; Ertel A; Lin J; Neilson LM; Rui H
Mol Cancer; 2013 Jun; 12():59. PubMed ID: 23758962
[TBL] [Abstract][Full Text] [Related]
34. Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.
Creamer BA; Sakamoto K; Schmidt JW; Triplett AA; Moriggl R; Wagner KU
Mol Cell Biol; 2010 Jun; 30(12):2957-70. PubMed ID: 20385773
[TBL] [Abstract][Full Text] [Related]
35. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141
[TBL] [Abstract][Full Text] [Related]
36. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
37. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development.
Grimm SL; Seagroves TN; Kabotyanski EB; Hovey RC; Vonderhaar BK; Lydon JP; Miyoshi K; Hennighausen L; Ormandy CJ; Lee AV; Stull MA; Wood TL; Rosen JM
Mol Endocrinol; 2002 Dec; 16(12):2675-91. PubMed ID: 12456789
[TBL] [Abstract][Full Text] [Related]
38. Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis.
Boyango I; Barash U; Fux L; Naroditsky I; Ilan N; Vlodavsky I
Matrix Biol; 2018 Jan; 65():91-103. PubMed ID: 28916201
[TBL] [Abstract][Full Text] [Related]
39. Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells.
Kavarthapu R; Dufau ML
Oncotarget; 2016 Oct; 7(40):65602-65613. PubMed ID: 27564112
[TBL] [Abstract][Full Text] [Related]
40. Stathmin Is Required for Normal Mouse Mammary Gland Development and Δ16HER2-Driven Tumorigenesis.
Segatto I; Zompit MM; Citron F; D'Andrea S; Vinciguerra GLR; Perin T; Berton S; Mungo G; Schiappacassi M; Marchini C; Amici A; Vecchione A; Baldassarre G; Belletti B
Cancer Res; 2019 Jan; 79(2):397-409. PubMed ID: 30478213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
